In vivo comparison of transduction efficiency with recombinant adenovirus-mediated p53 in a human colon cancer mouse model by different delivery routes

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 12, 2008, Pages 704-708

  Xie, Qi ^a   Liang, Biling ^b   Zhang, Jing ^a   Yang, Qihua ^b   Gu, Xiongfei ^c   Xu, Jing ^a   Chen, Mingwang ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatic allograft model; Human colon cancer; Nude mouse; rAd p53

Indexed keywords

EID: 58049213340     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-008-0123-y     Document Type: Article

References (21)

1. Baek JH, Agarwal ML, Tubbs RR, et al. In vivo recombinant adenovirus-mediated P53 gene therapy in a syngeneic rat model for colorectal cancer. J Korean Med Sci, 2004, 19: 831-841.
2. Tamm I, Schumacher A, Karawajew L, et al. Adenovirus-mediated gene transfer of P16INK/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo. Cancer Gene Ther, 2002, 9: 641-650.
3. Shimada H, Shimizu T, Ochai T, et al. Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today, 2001, 31: 597-604.
4. Kim YI, Chung JW, Park JK, et al. Intraarterial gene delivery in rabbit hepatic tumors: Transfection with nonviral vector by using iodized oil emulsion. Radiology, 2006, 240: 771-777.
5. Hannay, Davas JJ, Yu D, et al. Isolated limb perfusion: A noval delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma. Gene Ther, 2007, 14: 671-681.
6. Chung YL, Troy H, Banerji U, et al. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAGA) in human colon cancer models. J Natl Cancer Inst, 2003, 95: 1624-1633.
7. Ohashi M, Kanai F, Tateishi K, et al. Target gene therapy for α-Fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. Biochem Biophys Res Commun, 2001, 282: 529-535.
8. Block A, Freund CT, Chen SH, et al. Gene therapy of metastatic colon carcinoma: Regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase. Cancer Gene Ther, 2000, 7: 438-445.
9. Wang W, El-Deiry WS. Bioluminescent molecular imaging of endogenous exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther, 2003, 2: 196-202.
10. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol, 1989, 24: 148-154.
11. Okimoto T, Yahata H, Itou H, et al. Safety and growth suppressive effect of intra-hepatic arterial injection of AdCMV-p53 combined with CDDP to rat liver metastatic tumors. J Exp Clin Cancer Res, 2003, 22: 399-406.
12. Abe T, Wakimoto H, Bookstein R, et al. Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors. Cancer Gene Ther, 2002, 9: 228-235.
13. Shimada H, Matsubara H, Shiratori T, et al. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci, 2006, 97: 554-561.
14. Guan YS, Sun L, Zhou XP, et al. Intratumoral injection of recombinant adenovirally-mediaed p53 (rAd/p53) gene combined with transcatheter arterial embolization for treatment of primary hepatic carcinoma. World J Digestol (Chinese), 2005, 13: 125-127.
15. Tada M, Hatano E, Taura K, et al. High volume hydrodynamic injection of gene expression in rat hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine. J Gene Med, 2006, 8: 1018-1026.
16. Guan YS, Liu y, Zhou XP, et al. p53 gene (Gendicine) and embolisation overcome recurrent hepatocellular carcinoma. World J Gastroenterol, 2005, 11: 3803-3805.
17. Menon AG, Kuppen PJK, Burg SH van der, et al. Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. Cancer Gene Therapy, 2003, 10:509-517.
18. Roth JA. Adenovirus p53 gene therapy. Expert Opin Biol Ther, 2006, 6: 55-61.
19. Guan YS, La Z, Yang L, et al. p53 gene in treatment of hepatic carcinoma: Status quo. World J Gastroenterol, 2007, 13: 985-992.
20. Kim JW, Lee HS. Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model. Int J Mol Med. 2004, 14: 529-535.
21. Heise C, Sampson-Johannes A, Williams A, et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med, 1997, 3: 639-645.